Image For Activity Cover
GRHRRPEM2401 - CME/CMLE NGS Testing for DNA Repair Gene Mutations in Prostate Cancer
Course Description

NGS Testing for DNA Repair Gene Mutations in Prostate Cancer
This activity is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving their knowledge, skills, and competence related to NGS testing and reporting in prostate cancer. 

Course topics include:  

  • Advantages of NGS testing and reporting in prostate cancer 

  • Strategies to effectively test for homologous recombination repair mutations in prostate cancer 

  • Considerations for NGS adoption, including:  

  • Specimen quality/adequacy and testing 

  • Potential pitfalls 

  • Available diagnostic tests for HRR mutations 

  • NGS reporting considerations  

  • Importance of partnering with the multidisciplinary cancer care team to utilize NGS testing for patients with prostate cancer 

Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.

 
Faculty/Authors
Colin C. Pritchard, M.D., Ph.D.
Associate Professor of Laboratory Medicine, University of Washington (UW)
Director of the Genetics and Solid Tumors Laboratory at UW Medical Center
Seattle, WA 

Physician's Competency: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement 

CME/CMLE Credit: 0.5
Estimated Completion Time: 0.5 hour
Format: Online educational activity

Credit Designation Statement

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
 
The ASCP designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
 
ASCP designates this activity for a maximum of 0.5 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.
 
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

Method of Participation

To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.  

Commercial Support
This activity is funded by an independent educational grant from Pfizer. 


Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 3/15/2024     
Review Date:
Expiration Date: 3/15/2027      




Course Objectives

Upon completion of this activity, you will be able to:

  • Implement strategies to effectively test for HRR mutations based on expert guidance on timing and testing methodologies from blood or tissue

  • Apply multidisciplinary care team communication and workflow strategies for pathological reporting of HRR mutations, considering the implications of misdiagnosis and suboptimal treatment regimens.

Summary
Availability: On-Demand
Credit Offered:
0.5 CME/CMLE Credit
Powered By